Government of Ireland Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2016
NCT03394807
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Health Service Executive, Ireland

Active Ingredients

Drugs in Phase 4 Trials (1)

levobupivacaine (chirocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cholecystolithiasis (Phase 4)

Cholelithiasis (Phase 4)

Gallstones (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1